Clinical Trials Directory

Trials / Conditions / Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

137 registered clinical trials studyying Uterine Cervical Neoplasms29 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingHuman Papillomavirus (HPV) Self-Sampling Options to Promote Equity
NCT07214506
University of ArizonaN/A
RecruitingA Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Can
NCT07305727
Centre Hospitalier Universitaire de Nīmes
Not Yet RecruitingA Chinese Cohort of Cervical Large Cell Neuroendocrine Carcinoma
NCT07240753
Lili
Not Yet RecruitingPost-TRaUmatic STress Disorder Induced by Gynecological Brachytherapy
NCT07204535
Centre Paul Strauss
Not Yet RecruitingPatient Journey in Advanced Gynecologic Cancers
NCT07015593
Tongji Hospital
RecruitingVideo-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women
NCT07011836
ISA Associates, Inc.N/A
CompletedUS Radiomics in Advanced Cervical Cancer
NCT06984289
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RecruitingValidation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer
NCT06815939
DL AnalyticsN/A
RecruitingExploratory Study on NIRFI Technology Combined with ICG Guided Cervical Cancer Lymph Node Metastasis
NCT06840418
Obstetrics & Gynecology Hospital of Fudan UniversityN/A
RecruitingNeoadjuvant Therapy in Cervical Cancer
NCT06558682
Qilu Hospital of Shandong UniversityN/A
CompletedGastric-type Endocervical Adenocarcinoma: a Population-based Cohort Study
NCT06897306
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
RecruitingEvaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Se
NCT06528184
National Healthcare Group PolyclinicsN/A
Not Yet RecruitingA Prospective Cohort Study Comparing AI Prediction Model With Imaging Assessment to Diagnose Lymph Node Metast
NCT06541288
Obstetrics & Gynecology Hospital of Fudan UniversityN/A
RecruitingComparison of Conventional and Hypofractionated IMRT in High-Risk Cervical Cancer Post-Radical Hysterectomy
NCT06509724
Samsung Medical CenterPhase 3
RecruitingA Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
NCT06380816
Cancer Research UKPhase 1 / Phase 2
RecruitingA Study of LY4170156 in Participants With Selected Advanced Solid Tumors
NCT06400472
Eli Lilly and CompanyPhase 1
RecruitingCervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe
NCT07202936
University of Bern
Not Yet RecruitingClinical Study on the Evaluation of the Efficacy of Cervical Cancer
NCT06254729
First Affiliated Hospital Xi'an Jiaotong University
RecruitingA Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy
NCT06023862
Yonsei UniversityPhase 2
RecruitingAI Model for Cervical Cancer Detection From Colposcopy Images
NCT06644248
Bangladesh University of Engineering and Technology
UnknownSexual Function, Coping and Dyadic Coping in Patients With Cervical Cancer
NCT06124040
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RecruitingHTL0039732 in Participants With Advanced Solid Tumours
NCT05944237
Cancer Research UKPhase 1 / Phase 2
UnknownThe Long-term Benefit of Hydrogel Spacer in Reducing Rectal Radiation Dose in Cervical Cancer Radiation Therap
NCT05902390
Peking Union Medical College HospitalN/A
Not Yet RecruitingCadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immun
NCT05824494
Women's Hospital School Of Medicine Zhejiang UniversityPhase 2
RecruitingEarly Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy
NCT05793749
Chongqing University Cancer HospitalN/A
UnknownTislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
NCT05588219
Yong Zhang,MDPhase 2
UnknownDetection of Minimal Residual Disease Based on HPV ctDNA in Cervical Cancer
NCT05531981
Peking Union Medical College Hospital
UnknownFirst-in-human (FIH) Phase I Trial of BS-006 in Cervical Cancer
NCT05393440
Zhongnan HospitalPhase 1
RecruitingNivolumab-ipilimumab and Chemoradiation for Cervical Cancer
NCT05492123
Hospital Israelita Albert EinsteinPhase 2
UnknownEvaluate the Effect of ReSpace™ Hydrogel on Reducing Rectal Radiation Dose in Radiotherapy for Cervical Cancer
NCT05690906
Peking Union Medical College HospitalPhase 2
RecruitingConcurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer
NCT05735145
Fourth Affiliated Hospital of Guangxi Medical UniversityPhase 3
CompletedImpact of the Different Information Channels in Reducing Anxiety in Participants of Cervical Cancer Screening
NCT05622760
Biogipuzkoa Health Research InstituteN/A
RecruitingPROTECT: On-line Adaptive Proton Therapy for Cervical Cancer
NCT05406856
Leiden University Medical CenterN/A
CompletedFeasibility of ReSpace™ Hydrogel to Establish a Stable Cervical-rectal Space
NCT05369221
Peking Union Medical College HospitalPhase 1
TerminatedA Study of SGN-ALPV in Advanced Solid Tumors
NCT05229900
Seagen Inc.Phase 1
UnknownH101 Combined With Camrelizumab for Recurrent Cervical Cancer
NCT05234905
Zhejiang Cancer HospitalPhase 2
RecruitingRetrospective Study of Brachytherapy
NCT05242861
Zhejiang Cancer Hospital
CompletedSafety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid
NCT05578820
Gene Surgery LLCPhase 1
Active Not RecruitingEpidemiological Landscape of Cervical Cancer in Latin America
NCT04947605
Latin American Cooperative Oncology Group
UnknownUrinary and Vaginal HPV Testing in Cervical Cancer Screening
NCT05065853
University of Aarhus
CompletedMK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005)
NCT05007106
Merck Sharp & Dohme LLCPhase 2
CompletedEffect of Pelvic Radiotherapy on the Intestinal Microbiome and Metabolome
NCT04995809
The Christie NHS Foundation Trust
CompletedEarly Feasibility Study of the "Easy Light" Fluorecence Imaging System
NCT05004623
Professor Fernando Figueira Integral Medicine InstituteN/A
Active Not RecruitingNimotuzumab High-risk, Locally Advanced Squamous Cell Carcinoma of the Cervix
NCT06771596
Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2
CompletedEvidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
NCT04557423
Fox Chase Cancer CenterN/A
UnknownConcurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer
NCT04772001
Zhongnan HospitalN/A
UnknownA Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer
NCT05105672
The Affiliated Hospital of Xuzhou Medical UniversityPhase 2
RecruitingClinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet
NCT04733820
Huazhong University of Science and TechnologyPhase 3
Active Not RecruitingPostoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeu
NCT04723875
Huazhong University of Science and TechnologyPhase 3
TerminatedA Study of SGN-STNV in Advanced Solid Tumors
NCT04665921
Seagen Inc.Phase 1
TerminatedE7 TCR T Cell Induction Immunotherapy for Stage IIB-IVA Cervical Cancer
NCT04476251
National Cancer Institute (NCI)EARLY_Phase 1
Active Not RecruitingBasket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
NCT04579380
Seagen, a wholly owned subsidiary of PfizerPhase 2
UnknownQM-B and QM-C Hysterectomy for Early Cervical Cancer
NCT04691453
Southern Medical University, ChinaN/A
CompletedHPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study
NCT04694495
Zhujiang Hospital
RecruitingA Study of Sigvotatug Vedotin in Advanced Solid Tumors
NCT04389632
Seagen, a wholly owned subsidiary of PfizerPhase 1
CompletedStudy of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervi
NCT04221945
Merck Sharp & Dohme LLCPhase 3
CompletedImpact of the COVID-19 Pandemic in Gynecological Oncology
NCT04351139
Hospices Civils de Lyon
CompletedBintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer
NCT04246489
EMD Serono Research & Development Institute, Inc.Phase 2
UnknownCombination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer
NCT04096911
Buhai WangPhase 2
UnknownPelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer
NCT03955367
Peking Union Medical College HospitalPhase 3
UnknownChemotherapy With Anlotinib in Advanced Cervical Cancer
NCT04695535
Yang Shen
UnknownSUCCOR-Surgery in Cervical Cancer Comparing Different Surgical Aproaches in Stage IB1 Cervical Cancer
NCT03958305
Clinica Universidad de Navarra, Universidad de Navarra
UnknownScreening Test Accuracy of Gynocular™, HR-HPV Testing, VIA for Detection of Cervical Neoplastic Lesions, in Wo
NCT03931083
University of Bern
UnknownSentinel Lymph Node Mapping In Cervical Cancer
NCT03778268
Peking University People's HospitalN/A
UnknownLongitudinal Study of Different Surgical Approaches in Chinese Patients of Uterine Cervical Cancer
NCT03738969
Lei Li
UnknownPostoperative Concurrent Chemoradiotherapy Combined With Endostar for High-risk Early Stage Cervical Cancer
NCT03622827
Nanjing Medical UniversityPhase 2
CompletedThe Role of Clean Intermittent Catheterization in Patients Undergoing Radiotherapy After Radical Hysterectomy
NCT05410444
Zhejiang Cancer HospitalN/A
CompletedSafety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females
NCT03546842
Merck Sharp & Dohme LLCPhase 3
UnknownThe Biomarker Analysis in Locally Advanced Cervical Cancer
NCT03635216
Mackay Memorial Hospital
CompletedOncological Outcome After Completing or Abandoning (Radical) Hysterectomy in Patients With Cervical Cancer and
NCT04037124
General University Hospital, Prague
TerminatedHyperpolarized 13C MR Imaging of Lactate in Patients With Locally Advanced Cervical Cancer (LACC) Cervical Can
NCT03129776
Sunnybrook Health Sciences CentrePhase 1
TerminatedCureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physicia
NCT02900248
CureOne
UnknownObservation and Evaluation of Short-term Curative Effect of Local Advanced Cervical Cancer Treated With Partic
NCT03225443
Shanghai First Maternity and Infant Hospital
UnknownAdjuvant Protontherapy of Cervical and Endometrial Carcinomas
NCT03184350
Heidelberg UniversityN/A
UnknownImproving Access to Cervical Cancer Screening
NCT03118258
Médecins du MondeN/A
UnknownSentinel Node Mapping in Women With Endometrial and Cervical Cancer
NCT02820506
University of Southern DenmarkN/A
CompletedSentinel Node Mapping in Women With Cervical and Endometrial Cancer
NCT02825355
University of Southern Denmark
CompletedPerceived Barriers of Cervical Cancer Screening in Reunion Island and Key Levers for Improvment
NCT02907970
Centre Hospitalier Universitaire de la Réunion
UnknownSurvival Outcomes of Uterine Cervical Malignancies in Chinese Population
NCT03291236
Lei Li
CompletedSafety and Tolerability Evaluation Study of BVAC-C in Patients With HPV Type 16 or 18 Positive Cervical Cancer
NCT02866006
Cellid Co., Ltd.Phase 1 / Phase 2
WithdrawnA Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced
NCT02501278
European Organisation for Research and Treatment of Cancer - EORTCPhase 2
CompletedEffect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Te
NCT02651883
UNC Lineberger Comprehensive Cancer CenterN/A
RecruitingImage Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer
NCT03617133
Medical University of ViennaPhase 2
CompletedExclusion of Non-involved Uterus From the Target Volume in Locally Advanced Cervical Cancer
NCT03542942
University Hospital, GhentN/A
CompletedEffect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy
NCT02786524
University of MichiganN/A
UnknownSpecific Molecular Signatures Predict Neoadjuvant Chemotherapy Response in Cervical Cancer
NCT03229187
Huazhong University of Science and Technology
TerminatedA Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Patho
NCT02509585
Cardinal Health 414, LLCPhase 2
CompletedTrial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Smal
NCT02487095
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedThe Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomi
NCT02394652
University Health Network, TorontoPhase 2
UnknownA Trial of Tamoxifen and Letrozole in Recurrent and Persistent Squamous Cell Carcinoma of the Cervix
NCT02482740
Buddhist Tzu Chi General HospitalPhase 2
CompletedLESs Surgical Radicality for EaRly Stage Cervical Cancer
NCT02613286
Hospital de Câncer de PernambucoN/A
CompletedGuided Imagery in the Perioperative Period in Gynecologic Oncology Patients
NCT02444195
University of MichiganN/A
CompletedIrreversible Electroporation(IRE) For Uterine Cervical Neoplasms
NCT02430610
Fuda Cancer Hospital, GuangzhouN/A
CompletedPreventive Sexual Health Screening Among Female-to-Male (FTM) Transgender Adult Patients
NCT02401867
Fenway Community Health
Completed2D Versus 3D Radical Laparoscopic Hysterectomy for Cervical Cancer: a Prospective Randomized Trial
NCT02320578
Catholic University of the Sacred HeartN/A
CompletedCognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study
NCT03270995
McGill UniversityN/A
CompletedThe Kilimanjaro Cervical Screening Project
NCT01968837
Queen's UniversityN/A
CompletedENGOT-cx1/BGOG-cx1: 3 Weekly Carboplatin/Paclitaxel With or Without Nintedanib in Cervix Cancer
NCT02009579
Belgian Gynaecological Oncology GroupPhase 2
UnknownThe Effect of Postoperative Therapy on the Quality of Life of Patients With Early Cervical Cancer Research
NCT02018003
Peking University
UnknownHPV-test, Cervical Cancer and Follow-up
NCT02096016
University of Aarhus
CompletedClinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens
NCT01944722
Becton, Dickinson and CompanyN/A
CompletedMR Metabolic Biomarkers for Cervical Cancer
NCT01874548
Chang Gung Memorial Hospital
CompletedConducting Outreach to Improve Cervical Cancer Screening Rates Among Underscreened Patients
NCT02427399
Fenway Community HealthN/A
CompletedA Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer Patients
NCT01755897
Huazhong University of Science and TechnologyN/A
Completed[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
NCT01717391
John M. BuattiPhase 2
CompletedEuropean Clinical Evaluation of the BD HPV Assay on the BD Viper LT System
NCT01671462
Becton, Dickinson and Company
CompletedA Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
NCT01654458
Women's College HospitalN/A
TerminatedFDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer
NCT02317302
Washington University School of MedicinePhase 1
UnknownEarly Detection of Cancers in Low Resource Countries
NCT01178736
Woman's Cancer Foundation
UnknownRepetitive Functional Imaging in Locally Advanced Cervical Cancer
NCT01989364
Aarhus University Hospital
CompletedMRI (Including Spectroscopy and Fat-Saturations and Diffusion-Weighted Imaging) in Cervical Cancer
NCT01060033
Washington University School of MedicineN/A
CompletedLow-Cost Molecular Cervical Cancer Screening Study
NCT01231945
National Cancer Institute (NCI)
TerminatedA Pilot Study of Radiation-Immune Cell Combination Therapy in Cervical Cancer
NCT01194609
Korea Cancer Center HospitalPhase 1 / Phase 2
CompletedAn HPV Vaccine Provider Intervention in Safety Net Clinics
NCT02808832
Meharry Medical CollegeN/A
TerminatedIntended Use Study of the BD SurePath Plus™ Pap
NCT01234480
Becton, Dickinson and Company
UnknownEconomic Evaluation of Three Populational Screening Strategies for Cervical Cancer
NCT01373723
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i GurinaN/A
CompletedSafety and Tolerability of Cidofovir Gel Applied on Cervix Squamous Lesions
NCT00989443
Mithra PharmaceuticalsPhase 1
CompletedImaging the Uterine Cervix - UltraSightHD™
NCT01090635
STI-Medical Systems
TerminatedFLT PET Imaging for Cervical Cancer
NCT01075412
University of IowaPhase 2
CompletedSelf-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
NCT01014026
University Hospital, ToursPhase 3
TerminatedStudy of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women
NCT00966992
Washington University School of MedicinePhase 2
CompletedHuman Papillomavirus Epidemiology in Nigeria
NCT00804466
National Cancer Institute (NCI)N/A
CompletedRole of Bladder Training During Post-operative Hospital Stay After Radical Hysterectomy in Patients
NCT01907646
Catholic University of the Sacred HeartPhase 2
CompletedCost-Effectiveness and Patients Satisfaction of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic On
NCT02865889
Institut Paoli-Calmettes
CompletedChemotherapy / Radiotherapy in Uterine Cervical Neoplasms
NCT03238261
Instituto Nacional de Cancerologia, ColumbiaN/A
CompletedExpression of Oncogenic Human Papillomavirus E6/E7 Protein in Tampon Self-Tests
NCT00526370
University of Aarhus
Completed4 Versus 6 Courses of Adjuvant Chemotherapy in LACC Patients Previously Treated With NACT Plus Radical Surgery
NCT02365935
Campus Bio-Medico UniversityN/A
CompletedCervix Cytological Screening - Comparison of Tampon Self-Test and the Routine Smear.
NCT00377845
University of AarhusEARLY_Phase 1
UnknownHypoxia Imaging With 18F FAZA. Prognostic Impact in Cervical Cancer
NCT00388687
Medical University of Vienna
UnknownTissue Bank of Biological Specimens From Patients With Gynecologic Disease
NCT00299481
U.S. Army Medical Research and Development Command
CompletedPelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients
NCT00359866
Washington University School of MedicinePhase 1
UnknownQuestionnaire Study for Gynecological Cancer Survivors
NCT00391664
U.S. Army Medical Research and Development Command
CompletedTrial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)
NCT00295789
Haruhiko FukudaPhase 3
CompletedFacilitating Follow-Up Adherence for Abnormal Pap Smears
NCT01561326
Fox Chase Cancer CenterN/A
CompletedIrinotecan Study For Cervical Cancer
NCT00136955
PfizerPhase 2
RecruitingInstitut Paoli Calmettes Cervical Cancer Database
NCT02869490
Institut Paoli-Calmettes
Active Not RecruitingAscertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
NCT00579163
Memorial Sloan Kettering Cancer Center